This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Allergic Rhinoconjunctivitis
and you are
between 18 and 65
years old
This is an advanced phase trial assessing
the effectiveness of the new treatment before being released on the market.
Show me locations

The purpose

The purpose of this study is to assess the tolerability of AVANZ.

Provided treatments

  • Drug: AVANZ Phleum pratense

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01454531. The sponsor of the trial is ALK-Abelló A/S and it is looking for 199 volunteers for the current phase.
Official trial title:
An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy